SCHEMBL21157356

SCHEMBL21157356

CCOC(=O)c1cc2cc(-c3ccc(OC)c(OC)c3)cn2c(C(C)=O)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.44
LMNA P02545 5/20 0.44
HTT P42858 2/20 0.44
GLA P06280 1/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43
TUBB8 Q3ZCM7 1/20 0.43
TUBA3E Q6PEY2 1/20 0.43
TUBA1A Q71U36 1/20 0.43
TUBA1C Q9BQE3 1/20 0.43
TUBB6 Q9BUF5 1/20 0.43
TUBB2B Q9BVA1 1/20 0.43
TUBB1 Q9H4B7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19964980 0.88 EED (0.43) MAPTLMNAHTTSMN1; SMN2HPGD
SCHEMBL21113050 0.87 ALDH1A1 (0.41) MAPTLMNAHTTGLASMN1; SMN2
SCHEMBL21113459 0.86 ALDH1A1 (0.37) MAPTLMNAGLASMN1; SMN2HPGD
SCHEMBL19964838 0.85 ERN1 (0.39) MAPTLMNAGLASMN1; SMN2GAA
SCHEMBL21113062 0.84 ALDH1A1 (0.46) SMN1; SMN2HPGDTP53USP2KDM4E
SCHEMBL21156562 0.84 HPGD (0.37) MAPTLMNAHTTGLASMN1; SMN2
SCHEMBL21113224 0.83 ALDH1A1 (0.44) MAPTGLASMN1; SMN2HPGDGAA
SCHEMBL21113076 0.82 MAPT (0.41) MAPTLMNAHTTGLASMN1; SMN2
SCHEMBL21113246 0.82 BAZ2B (0.38) MAPTLMNAGLASMN1; SMN2HPGD
SCHEMBL19964897 0.81 CASP1 (0.45) MAPTHPGDUSP2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof EZH2, IKZF2, SUZ12 MAPT 4100/4885LMNA 2826/4885HTT 4433/4885
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF EZH2, IKZF2, SUZ12 MAPT 4100/4885LMNA 2826/4885HTT 4433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.